Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07776106
Active, not recruiting Observational

The Perspectives of Those Who Experienced the Kahramanmaraş Earthquake

NCT07776106 · tracked via the Priya Life Science Turkey tracker
Sponsor
Zülal TATAR
Phase
Observational
Started
2026-07-22
Last updated
2026-08-24

Condition(s) studied

Earthquake

Study summary

The aim of this study was to explore the perspectives of individuals who experienced the Kahramanmaraş earthquake through a qualitative approach.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Having experienced the Kahramanmaraş earthquake * Being 18 years of age or older, * Agreeing to participate in the study Exclusion Criteria: * The presence of medical/psychiatric conditions that may affect study measurements (e.g., neurological disorders, severe psychiatric illness) * Individuals with orthopedic, neurological, or other problems that developed before or due to the earthquake and that may prevent the participant from participating in the assessments

Primary outcome measure(s)

  • Open-Ended Questionnaire — At baseline (Day 1)
    Participants will be asked 7 open-ended questions about how they were affected by the Kahramanmaraş earthquake, how their lives changed, and how they returned to their normal daily routines: What was the biggest change in your life after the earthquake? What was the most important thing that kept you going after the earthquake? What is the most important lesson you learned from your earthquake experience? What factors made it easier to return to your normal daily routine after the earthquake? What factors made it difficult to return to your normal daily routine after the earthquake? How did the earthquake affect you psychologically? How long did you stay in temporary shelter after the earthquake?

Trial sites (1)

FacilityCityRegionStatus
Pamukkale University Denizli Turkey (Türkiye)

More Zülal TATAR trials in Turkey

Factors Associated With Cognitive Skills in Patients With Fibromyalgia Enrolling by invitation
Assessment of Pain Experience in Fibromyalgia Enrolling by invitation
The Role of Isometric in Individuals With Rheumatoid Arthritis Enrolling by invitation

Other trials for the same condition

Home Visit Simulation-based Earthquake Preparedness Training for Nursing Students Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07776106 on ClinicalTrials.gov ↗ ← All trials in Turkey